Ironwood Pharmaceuticals Stock Investor Sentiment

IRWD Stock  USD 1.41  0.12  7.84%   
About 63% of Ironwood Pharmaceuticals' investor base is looking to short. The analysis of the overall investor sentiment regarding Ironwood Pharmaceuticals suggests that many traders are alarmed. The current market sentiment, together with Ironwood Pharmaceuticals' historical and current headlines, can help investors time the market. In addition, many technical investors use Ironwood Pharmaceuticals stock news signals to limit their universe of possible portfolio assets.
  
a day ago at gurufocus.com         
Sarissa Capital Management LP Reduces Stake in Innoviva Inc.
Gurufocus Stories at Macroaxis
few days ago at www.macroaxis.com         
Acquisition by Denner Alexander J of 2572 shares of Ironwood Pharmaceuticals subject to Rule 16b-3
Macroaxis News
few days ago at thelincolnianonline.com         
Ironwood Pharmaceuticals, Inc. Shares Sold by Vestcor Inc
news
over a week ago at www.macroaxis.com         
Insider Trading
Macroaxis News
over a week ago at www.macroaxis.com         
Insider Trading
Macroaxis News
over two weeks ago at www.macroaxis.com         
Acquisition by Shetzline Michael of 34936 shares of Ironwood Pharmaceuticals subject to Rule 16b-3
Macroaxis News
over two weeks ago at news.google.com         
Is Ironwood Pharmaceuticals, Inc. the Best Small Cap Pharma Stock to Buy Now - Insider Monkey
Google News at Macroaxis
over two weeks ago at gurufocus.com         
Q4 2024 Ironwood Pharmaceuticals Inc Earnings Call Transcript
Gurufocus Stories at Macroaxis
over two weeks ago at insidermonkey.com         
Ironwood Pharmaceuticals, Inc. Q4 2024 Earnings Call Transcript
insidermonkey News
over two weeks ago at finance.yahoo.com         
IRWDs Q4 Earnings and Revenues Fall Shy of Estimates, Stock Down
Yahoo News
over two weeks ago at gurufocus.com         
Ironwood Pharmaceuticals Inc Q4 2024 Earnings Call Highlights Strong Prescription ...
Gurufocus Stories at Macroaxis
over two weeks ago at zacks.com         
IRWDs Q4 Earnings and Revenues Fall Shy of Estimates, Stock Down
zacks News
over three weeks ago at finance.yahoo.com         
Ironwood Q4 Earnings Snapshot
Yahoo News
over three weeks ago at finance.yahoo.com         
Ironwood Pharmaceuticals Q4 Earnings and Revenues Miss Estimates
Yahoo News
over three weeks ago at thelincolnianonline.com         
Ironwood Pharmaceuticals Releases Quarterly Earnings Results
news
Far too much social signal, news, headlines, and media speculation about Ironwood Pharmaceuticals that are available to investors today. That information is available publicly through Ironwood media outlets and privately through word of mouth or via Ironwood internal channels. However, regardless of the origin, that massive amount of Ironwood data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Ironwood Pharmaceuticals news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Ironwood Pharmaceuticals relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Ironwood Pharmaceuticals' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Ironwood Pharmaceuticals alpha.

Ironwood Pharmaceuticals Performance against Dow Jones

 Price Growth (%)  
       Timeline  

Complementary Tools for Ironwood Stock analysis

When running Ironwood Pharmaceuticals' price analysis, check to measure Ironwood Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ironwood Pharmaceuticals is operating at the current time. Most of Ironwood Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Ironwood Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ironwood Pharmaceuticals' price. Additionally, you may evaluate how the addition of Ironwood Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities